Yield Growth Reports Q3 Results with Consistent Revenue Growth over 6 Consecutive Quarters with Revenue of $1.9 Million in Q3, up 61 Percent from Q2 Cannabis Investing News
Isracann Biosciences Launches Phase One Facility Development Program in Israel Cannabis Investing News